Furthermore, administration of GSNO in the same model attenuated hyperglycemia-induced EZH2-H3K27me3 activation, endothelial inflammation and further diminished monocyte adhesion both in vitro and ex vivo. This evidence concerns the gene EZH2 and Hyperglycemia.